The fields of virus research and oncology are experiencing a period of unprecedented advancement. This convergence of innovation is driven by shared challenges, common therapeutic approaches, and a growing understanding of the nuances underlying both diseases. Recent breakthroughs in immunotherapy hold immense promise for treating not only HIV and

Cytomegalovirus (CMV), a prevalent virus, often infects humans globally. Though generally asymptomatic, CMV can pose significant health risks to weakened individuals, such as those with HIV/AIDS or undergoing organ transplantation.{Infection occurs through saliva, blood, urine, and other bodily fluids. Symptoms of CMV infection can range from mild